Anti-interleukin-33 antibodies and uses thereof

The invention provides interleukin-33 (IL-33) antibodies and methods of making and using the same, e.g., for treatment of IL-33 mediated disorders (e.g., ocular disorders such as AMD (e.g., geographic atrophy (GA)).

Saved in:
Bibliographic Details
Main Authors Nakamura, Gerald R, Chan, Hiu Nam, Van Lookeren Campagne, Menno, Seshasayee, Dhaya, Wong, Tiffany, Comps-Agrar, Laetitia, Corpuz, Racquel, Bevers, III, Jack, Wu, Jia, Xi, Hongkang
Format Patent
LanguageEnglish
Published 19.09.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention provides interleukin-33 (IL-33) antibodies and methods of making and using the same, e.g., for treatment of IL-33 mediated disorders (e.g., ocular disorders such as AMD (e.g., geographic atrophy (GA)).
Bibliography:Application Number: US202117199810